News | November 25, 2023
DxVx plans to make a license-in agreement of OVM-200
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Final stage in licensing OVM-200 from Oxford Vacmedix in the UK
Total transaction value of the divestment is Rs. 3,660 million
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports
hey were educated about the 7- step hand-washing technique trainings
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Alignment of carbon-fiber can be controlled during the 3D printing process
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Minister was briefed on the nationwide dengue situation
Subscribe To Our Newsletter & Stay Updated
